From: Development of a novel PRO instrument for use in familial chylomicronemia syndrome
Patient characteristic | Total (N = 10) |
---|---|
Sex, n (%) | |
Female | 7 (70.0) |
Male | 3 (30.0) |
Age in years, mean (range) | 53.0 (28–69) |
Race, n (%) | |
White | 10 (100.0) |
Education, n (%) | |
Some college | 2 (20.0) |
College degree | 3 (30.0) |
Some graduate school | 3 (30.0) |
Professional or advanced degree | 2 (20.0) |
Body mass index, mean (range) | 25.3 (18–34) |
FCS confirmed through genetic testing, n (%) | 9 (90.0) |
Participated in FCS clinical trial within the past 2 years, n (%) | 6 (60.0) |
Still taking study drug, n (%) | 4 (40.0) |
Diagnosed with diabetes, n (%) | 6 (60.0) |